CADILA HEALTHCARE LTD. - 532321 - Certificate Under Regulation 74(5)
Certificate under regulation 74(5) of SEBI (Depositories and Participants) Regulations, 201808-04-2021
08-04-2021
Zydus Cadila gets USFDA nod for cancer and high blood pressure, treatment drug
Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market Ibrutinib Capsules in the strengths of 70 mg and 140 mg, Cadila Healthcare said in a regulatory filing.08-04-2021
Cadila Healthcare Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus Cadila announces USFDA approval for First Generic for Ibrutinib Capsules, 70 mg and gets eligibility for 180-day exclusivity08-04-2021
Cadila Healthcare Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus Cadila announces final USFDA approval for Macitentan Tablets, 10 mg and gets eligibility for 180-day shared exclusivity08-04-2021
Cadila Healthcare: Street eyeing new covid drug approval, vaccine launch
India sales remain strong, with domestic formulations marking a strong 21% year-on-year growth, helped by speciality business and covid portfolio during Q306-04-2021
Cadila Seeks Nod To Repurpose Hepatitis C Drug For COVID-19 In India
A single dose of the Hepatitis C drug when taken early could help COVID-19 patients recover faster and avoid complications seen in the advanced stages of the disease, Cadila said.05-04-2021
CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus seeks DCGI approval for the use of Pegylated Interferon alpha-2b in treating COVID-1905-04-2021
CADILA HEALTHCARE LTD. - 532321 - Compliance Certificate For The Half Year Ended On March 31, 2021
Compliance Certificate for the half year ended on March 31, 202103-04-2021
CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
As per the attached letter.01-04-2021
CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
As per the attached letter31-03-2021